TUDCA treatment restores aortic and perivascular adipose tissue function in post-weaning protein-restricted mice

This study demonstrates that TUDCA treatment restores vascular and perivascular adipose tissue function in male mice subjected to post-weaning protein restriction by attenuating endoplasmic reticulum stress, fibrosis, and associated molecular dysregulation.

The Gist

The Big Picture: A "Bad Start" with a "Good Fix"

Imagine your body is like a high-performance car. The first few years of life (childhood) are like the factory assembly line. If the factory runs out of essential parts (like protein) while building the car, the engine and the suspension might be built a little "off."

This study looks at what happens when mice are given a diet low in protein right after they are weaned (like a baby being taken off the bottle). This "low protein" start causes the car to run poorly later in life: the brakes don't work well, the engine gets stiff, and the car runs hot (high blood pressure).

The researchers wanted to know: Can we fix this car later on? They tested a specific "repair kit" called TUDCA (a type of bile acid found in our bodies and used as a medicine) to see if it could repair the damage caused by that early bad diet.

---

The Main Characters

1. The Protein-Deprived Mice (The "Off-Spec" Cars): These mice were fed a diet with very little protein. As adults, their blood vessels (the pipes carrying blood) became stiff, their "brakes" (the ability to relax) stopped working, and the fat surrounding their blood vessels (PVAT) became dysfunctional.
2. TUDCA (The "Magic Wrench"): This is a chemical chaperone. Think of it as a mechanic who goes into the engine and helps the parts fold into their correct shapes so they work properly again.
3. ER Stress (The "Overheated Factory"): Inside our cells, there is a factory called the Endoplasmic Reticulum (ER) that builds proteins. When the body is stressed (like from a bad diet), this factory gets overwhelmed, parts get misshapen, and the whole system jams. This is called ER Stress. The study found this was the main reason the blood vessels were failing.

---

The Story Unfolds: What Happened?

1. The Problem: A Gender Gap

The researchers discovered something interesting: The "bad diet" hurt the male mice much more than the female mice.

• The Males: Their blood vessels became stiff, their blood pressure went up, and the fat surrounding their arteries stopped doing its job. It was like the rubber hoses around the engine had turned into concrete.
• The Females: They had the same bad diet, but their blood vessels stayed flexible and healthy. It seems female mice have a natural "shield" (likely hormones) that protects them from this specific type of damage.

2. The Villain: The "Sticky Fat" (PVAT)

Surrounding every blood vessel is a layer of fat called Perivascular Adipose Tissue (PVAT).

• In a healthy body: This fat acts like a smart lubricant. It releases chemicals that tell the blood vessel to relax and stay flexible.
• In the protein-starved males: This fat got sick. It shrank, lost its "lubricating" ability, and actually started making the blood vessel stiffer. It was like the lubricant turned into glue.

3. The Solution: TUDCA to the Rescue

The researchers gave the sick male mice TUDCA for the last two weeks of the experiment. The results were amazing:

• The "Factory" Cooled Down: TUDCA stopped the "ER Stress." It helped the protein factory get back to normal, so the cells stopped jamming.
• The "Glue" Turned Back to "Lubricant": The fat surrounding the blood vessels (PVAT) started growing back to a healthy size and began releasing the right chemicals again.
• The Vessels Flexed Again: The blood vessels could relax and contract properly. The blood pressure dropped back to normal levels.

4. The Secret Weapon: The "FXR" Switch

The study also found that TUDCA turned on a specific switch in the cells called FXR (a receptor). Think of FXR as a master control panel that tells the cells to stop inflammation and start healing. TUDCA flipped this switch, which helped fix both the blood vessels and the surrounding fat.

---

The Takeaway: Why Does This Matter?

This study tells us three important things in simple terms:

1. Early Nutrition Matters: What you eat as a child can "program" your blood vessels for life. A lack of protein can leave a hidden scar that causes heart problems decades later.
2. Men and Women React Differently: In this specific scenario, men were much more vulnerable to the damage than women. This highlights the need to study diseases differently based on sex.
3. There Might Be a Cure: Even if the damage happened years ago, it might be reversible. The drug TUDCA (which is already safe and approved for liver issues) acted like a "reset button" for the blood vessels. It didn't just treat the symptoms; it fixed the underlying "factory jam" (ER stress) that was causing the problem.

In a nutshell: If you build a house with bad materials, the walls might crack later. This study suggests that even if the walls are cracked, there is a special tool (TUDCA) that can patch the cracks and reinforce the structure, making the house safe again. This gives hope for treating heart problems caused by childhood malnutrition.

Technical Summary

1. Problem Statement

Early-life malnutrition, specifically protein restriction, is a known risk factor for the development of cardiovascular diseases (CVD) in adulthood. While it is established that low-protein diets during development lead to hypertension and endothelial dysfunction, the underlying molecular mechanisms and potential therapeutic interventions remain poorly defined.

• Specific Gap: The impact of protein restriction on Perivascular Adipose Tissue (PVAT)—a critical regulator of vascular tone—and the role of Endoplasmic Reticulum (ER) stress in mediating these vascular alterations were unknown.
• Sexual Dimorphism: Previous data suggested sex-specific vulnerabilities to malnutrition, but the mechanisms driving these differences in vascular health were not fully elucidated.
• Therapeutic Need: There is a lack of targeted strategies to mitigate the long-term vascular complications associated with early-life undernutrition.

2. Methodology

The study utilized a murine model to investigate the effects of post-weaning protein restriction and the therapeutic potential of Tauroursodeoxycholic acid (TUDCA).

• Animal Model: Male and female C57BL6/JUnib mice were subjected to a post-weaning diet (starting at 28 days) for 105 days.
  • Groups: Normoprotein diet (N, 14% protein) vs. Protein-restricted diet (R, 6% protein, isocaloric).
  • Intervention: In the final 15 days, mice received daily intraperitoneal injections of:
    • Vehicle (PBS)
    • TUDCA (300 mg/kg/day) – an ER stress inhibitor and chemical chaperone.
    • 4-Phenylbutyric acid (PBA) (300 mg/kg/day) – a second ER stress inhibitor used for mechanistic validation (in males only).
• Physiological Assessments:
  • Blood Pressure: Measured via plethysmography.
  • Vascular Reactivity: Thoracic aortas were isolated with (PVAT+) and without (PVAT-) perivascular adipose tissue. Contractile responses to Phenylephrine (PE) and KCl, and endothelium-dependent relaxation to Acetylcholine (ACh), were measured in an organ bath.
• Molecular and Histological Analyses:
  • Histology: Hematoxylin & Eosin (H&E) and Masson's Trichrome staining to assess adipocyte morphology and collagen deposition (fibrosis).
  • Gene Expression: qRT-PCR was performed on aorta and PVAT tissues to analyze markers for:
    • Vascular function: eNOS, $\alpha$-actin, SM22$\alpha$, Cav1.2.
    • PVAT function: PRDM16, PPAR$\gamma$, PGC1$\alpha$, UCP1, Leptin, Adiponectin, and their receptors.
    • ER Stress: GRP78, PERK, ATF6, IRE1$\alpha$, XBP1, ATF4, CHOP.
    • Bile Acid Receptors: FXR, TGR5, S1PR2.
    • Fibrosis: Collagen I, III, IV, TGF$\beta$.

3. Key Contributions

• Sex-Specific Vulnerability: The study confirmed that post-weaning protein restriction induces severe vascular dysfunction and PVAT remodeling in males, while females exhibit relative protection, maintaining normal vascular reactivity despite systemic metabolic changes.
• PVAT Dysfunction Mechanism: It identified that protein restriction causes a "lipodystrophy-like" remodeling in male PVAT, characterized by reduced lipid content, loss of thermogenic/adipogenic markers, and fibrosis, which directly contributes to the loss of the PVAT anticontractile effect.
• ER Stress as a Central Mediator: The research established ER stress as the primary mechanistic link between early-life protein restriction and long-term vascular/PVAT dysfunction.
• Therapeutic Efficacy of TUDCA: It demonstrated that TUDCA, by inhibiting ER stress and upregulating the Farnesoid X Receptor (FXR), can fully reverse vascular hypertension, endothelial dysfunction, hypocontractility, and PVAT fibrosis in protein-restricted males.

4. Key Results

Physiological and Vascular Function (Males)

• Protein Restriction (R): Caused reduced body weight, hypoproteinemia, and increased systolic blood pressure.
• Vascular Dysfunction: The R group exhibited:
  • Impaired endothelium-dependent relaxation (reduced ACh response).
  • Vascular hypocontractility (reduced PE and KCl response).
  • Loss of PVAT Anticontractile Effect: In normal mice, PVAT attenuates vasoconstriction; this protective effect was completely lost in the R group.
• TUDCA Treatment: Fully normalized blood pressure, restored endothelial relaxation, recovered contractile capacity, and reinstated the anticontractile effect of PVAT.

PVAT Remodeling

• Structural Changes: Protein restriction reduced PVAT lipid content and induced fibrosis (increased collagen deposition) in males.
• Molecular Changes: Downregulation of thermogenic (UCP1, PRDM16) and adipogenic (PPAR$\gamma$) markers, as well as vasodilator factors (Leptin, Ob-Rb, Adiponectin).
• Restoration: TUDCA treatment restored PVAT lipid content and normalized the expression of PRDM16, PPAR$\gamma$, Leptin, and Ob-Rb.

Molecular Mechanisms

• ER Stress: Protein restriction significantly upregulated ER stress markers (GRP78, PERK/ATF4/CHOP, IRE1$\alpha$/XBP1, ATF6) in both the aorta and PVAT. TUDCA normalized these markers.
• Fibrosis: Increased expression of Collagen I, III, IV, and TGF$\beta$ in the R group was reversed by TUDCA.
• Bile Acid Signaling: Protein restriction reduced the expression of the bile acid receptor FXR in both tissues. TUDCA treatment significantly upregulated FXR expression. TGR5 and S1PR2 were not significantly modulated.
• Validation: Treatment with PBA (another ER stress inhibitor) replicated the beneficial effects of TUDCA, confirming that ER stress inhibition is the critical mechanism.

Sexual Dimorphism

• Female mice on the protein-restricted diet showed reduced body weight and increased blood pressure but did not develop vascular dysfunction, endothelial impairment, or PVAT remodeling. Consequently, TUDCA treatment was only conducted in males.

5. Significance and Implications

• Clinical Relevance: The findings suggest that TUDCA, an FDA-approved drug for cholestatic liver disease, could be repurposed as an adjuvant therapy to prevent cardiovascular complications in individuals with a history of early-life malnutrition.
• Mechanistic Insight: The study highlights ER stress and FXR signaling as critical therapeutic targets for reversing malnutrition-induced vascular remodeling.
• Public Health: Given the rising global prevalence of undernutrition (exacerbated by the pandemic), identifying a pharmacological strategy to mitigate the "developmental programming" of cardiovascular disease is of high priority.
• Future Directions: The study points to the need for further investigation into the specific role of FXR agonism in mediating the vascular benefits of TUDCA and the mechanisms behind the observed sexual dimorphism in vascular resilience.